Cell Adhesion Molecules in Neuroblastoma: Complex Roles, Therapeutic Potential
Open Access
- 27 April 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 782186
Abstract
Neuroblastoma, a biologically heterogeneous tumor derived from neural crest cells, accounts for approximately 15% of childhood deaths from cancer. Recently, scientific literature has explored the role of cell adhesion molecules (CAMs) in cancer metastasis through cell detachment, migration, and invasion. Through a review of the current literature, it is evident that expression of different CAMs on neuroblastoma tumors is associated with favorable or unfavorable clinical prognosis. In patients diagnosed with neuroblastoma, treatment strategies include chemotherapy, surgery, radiotherapy, stem cell transplant, and more recently, immunotherapy and other targeted therapies. Long term survival remains poor despite multimodality treatment, especially for children with high-risk neuroblastoma, making it more necessary to explore innovative targeted therapies. CAMs have immense potential as therapeutic targets, but there is a need for growth and scientific exploration before CAM therapies become clinically useful.Keywords
This publication has 44 references indexed in Scilit:
- Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing programPediatric Blood & Cancer, 2013
- N-Cadherin in Neuroblastoma Disease: Expression and Clinical SignificancePLOS ONE, 2012
- Expression of the neural cell adhesion molecule and polysialic acid in human neuroblastoma cell linesInternational Journal of Oncology, 2011
- Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastomaBMC Cancer, 2009
- Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to BoneMolecular Cancer Research, 2008
- Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation statusPediatric Blood & Cancer, 2008
- NeuroblastomaSurgical Oncology, 2007
- Polysialic Acid Directs Tumor Cell Growth by Controlling Heterophilic Neural Cell Adhesion Molecule InteractionsMolecular and Cellular Biology, 2003
- Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: differential regulation of α2, α3 and β1Oncogene, 1997
- Expression of integrin receptors on 45 clinical neuroblastoma specimensInternational Journal of Cancer, 1991